198 related articles for article (PubMed ID: 35437261)
1. Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.
Wang Y; Pan Y; Li H; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Johnston SC
Neurology; 2022 Jul; 99(1):e46-e54. PubMed ID: 35437261
[TBL] [Abstract][Full Text] [Related]
2. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
[TBL] [Abstract][Full Text] [Related]
3. Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Johnston SC; Amarenco P; Aunes M; Denison H; Evans SR; Himmelmann A; Jahreskog M; James S; Knutsson M; Ladenvall P; Molina CA; Nylander S; Röther J; Wang Y;
Stroke; 2021 Nov; 52(11):3482-3489. PubMed ID: 34477459
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
N Engl J Med; 2020 Jul; 383(3):207-217. PubMed ID: 32668111
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.
Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Johnston SC;
Stroke; 2020 Dec; 51(12):3504-3513. PubMed ID: 33198608
[TBL] [Abstract][Full Text] [Related]
7. The Acute S
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
Int J Stroke; 2019 Oct; 14(7):745-751. PubMed ID: 30747613
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
Wong KSL; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Himmelmann A; Kasner SE; Knutsson M; Ladenvall P; Minematsu K; Molina CA; Wang Y; Johnston SC;
Stroke; 2018 Jul; 49(7):1678-1685. PubMed ID: 29915123
[TBL] [Abstract][Full Text] [Related]
9. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
[TBL] [Abstract][Full Text] [Related]
10. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Easton JD; Aunes M; Albers GW; Amarenco P; Bokelund-Singh S; Denison H; Evans SR; Held P; Jahreskog M; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
Circulation; 2017 Sep; 136(10):907-916. PubMed ID: 28655834
[TBL] [Abstract][Full Text] [Related]
11. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N;
Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700
[TBL] [Abstract][Full Text] [Related]
12. Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack.
Zhang J; Wang A; Tian X; Meng X; Xie X; Jing J; Lin J; Wang Y; Li Z; Liu L; Li H; Jiang Y; Zhao X; Wang Y
CMAJ; 2023 Jul; 195(26):E897-E904. PubMed ID: 37429630
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
Wang Y; Pan Y; Li H; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Birve F; Ladenvall P; Molina CA; Johnston SC;
JAMA Neurol; 2021 Sep; 78(9):1091-1098. PubMed ID: 34244703
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
[TBL] [Abstract][Full Text] [Related]
15. Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
Molina CA; Johnston SC; Ladenvall P; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Knutsson M; Minematsu K; Röther J; Wang Y; Wong KSL;
Stroke; 2019 Mar; 50(3):675-682. PubMed ID: 30776996
[TBL] [Abstract][Full Text] [Related]
16. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis.
Ma X; Li D; Liu S; Chen Y; Zhong P
Eur Neurol; 2023; 86(4):229-241. PubMed ID: 37068471
[TBL] [Abstract][Full Text] [Related]
18. Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
Xie X; Jing J; Meng X; Claiborne Johnston S; Bath PM; Li Z; Zhao X; Liu L; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
Stroke; 2023 Sep; 54(9):2241-2250. PubMed ID: 37548009
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KS;
N Engl J Med; 2016 Jul; 375(1):35-43. PubMed ID: 27160892
[TBL] [Abstract][Full Text] [Related]
20. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
Kim AS; Easton JD
Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
